TEPEZZA ^TM
(teprotumumab-trbw)
Now FDA Approved

We’re Horizon, a global biopharmaceutical company driven by a simple idea: we believe that science and compassion must work together to transform lives.

Our pipeline is built on purpose, and our scientific courage drives us to tackle many marginalized, overlooked or forgotten diseases.

At Horizon, we’re driven by a clear purpose; to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare and rheumatic diseases.

Click here to learn more about our new medicine, TEPEZZA^TM (teprotumumab-trbw).